These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22464963)

  • 1. The potential economic value of a Staphylococcus aureus vaccine among hemodialysis patients.
    Song Y; Tai JH; Bartsch SM; Zimmerman RK; Muder RR; Lee BY
    Vaccine; 2012 May; 30(24):3675-82. PubMed ID: 22464963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus vaccine for orthopedic patients: an economic model and analysis.
    Lee BY; Wiringa AE; Bailey RR; Lewis GJ; Feura J; Muder RR
    Vaccine; 2010 Mar; 28(12):2465-71. PubMed ID: 20064479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study.
    Fattom A; Matalon A; Buerkert J; Taylor K; Damaso S; Boutriau D
    Hum Vaccin Immunother; 2015; 11(3):632-41. PubMed ID: 25483694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential economic value of a Staphylococcus aureus vaccine for neonates.
    Lee BY; Ufberg PJ; Bailey RR; Wiringa AE; Smith KJ; Nowalk AJ; Higgins C; Wateska AR; Muder RR
    Vaccine; 2010 Jun; 28(29):4653-60. PubMed ID: 20472028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Would hemodialysis patients benefit from a Staphylococcus aureus vaccine?
    Connolly R; Denton MD; Humphreys H; McLoughlin RM
    Kidney Int; 2019 Mar; 95(3):518-525. PubMed ID: 30691691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis.
    Moustafa M; Aronoff GR; Chandran C; Hartzel JS; Smugar SS; Galphin CM; Mailloux LU; Brown E; Dinubile MJ; Kartsonis NA; Guris D
    Clin Vaccine Immunol; 2012 Sep; 19(9):1509-16. PubMed ID: 22837094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine.
    Marshall HS; Baber J; Richmond P; Nissen M; Shakib S; Kreiswirth BN; Zito ET; Severs J; Eiden J; Gruber W; Jansen KU; Jones CH; Anderson AS
    J Infect; 2019 Dec; 79(6):582-592. PubMed ID: 31585191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a future for a Staphylococcus aureus vaccine?
    Proctor RA
    Vaccine; 2012 Apr; 30(19):2921-7. PubMed ID: 22115633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients.
    Li Y; Friedman JY; O'Neal BF; Hohenboken MJ; Griffiths RI; Stryjewski ME; Middleton JP; Schulman KA; Inrig JK; Fowler VG; Reed SD
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):428-34. PubMed ID: 19118117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.
    Fowler VG; Allen KB; Moreira ED; Moustafa M; Isgro F; Boucher HW; Corey GR; Carmeli Y; Betts R; Hartzel JS; Chan IS; McNeely TB; Kartsonis NA; Guris D; Onorato MT; Smugar SS; DiNubile MJ; Sobanjo-ter Meulen A
    JAMA; 2013 Apr; 309(13):1368-78. PubMed ID: 23549582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.
    Schaffer AC; Solinga RM; Cocchiaro J; Portoles M; Kiser KB; Risley A; Randall SM; Valtulina V; Speziale P; Walsh E; Foster T; Lee JC
    Infect Immun; 2006 Apr; 74(4):2145-53. PubMed ID: 16552044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges for a universal Staphylococcus aureus vaccine.
    Proctor RA
    Clin Infect Dis; 2012 Apr; 54(8):1179-86. PubMed ID: 22354924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.
    Shinefield H; Black S; Fattom A; Horwith G; Rasgon S; Ordonez J; Yeoh H; Law D; Robbins JB; Schneerson R; Muenz L; Fuller S; Johnson J; Fireman B; Alcorn H; Naso R
    N Engl J Med; 2002 Feb; 346(7):491-6. PubMed ID: 11844850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model-based analysis: what potential could there be for a S. aureus vaccine in a hospital setting on top of other preventative measures?
    Hogea C; Van Effelterre T; Cassidy A
    BMC Infect Dis; 2014 May; 14():291. PubMed ID: 24884845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. I. Challenge trials.
    Leitner G; Lubashevsky E; Glickman A; Winkler M; Saran A; Trainin Z
    Vet Immunol Immunopathol; 2003 May; 93(1-2):31-8. PubMed ID: 12753773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis.
    Bloom BS; Fendrick AM; Chernew ME; Patel P
    Am J Kidney Dis; 1996 May; 27(5):687-94. PubMed ID: 8629629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage.
    Botelho-Nevers E; Verhoeven P; Paul S; Grattard F; Pozzetto B; Berthelot P; Lucht F
    Expert Rev Vaccines; 2013 Nov; 12(11):1249-59. PubMed ID: 24111513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureus.
    Misstear K; McNeela EA; Murphy AG; Geoghegan JA; O'Keeffe KM; Fox J; Chan K; Heuking S; Collin N; Foster TJ; McLoughlin RM; Lavelle EC
    J Infect Dis; 2014 May; 209(9):1479-84. PubMed ID: 24273045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection.
    Liu Q; Du X; Hong X; Li T; Zheng B; He L; Wang Y; Otto M; Li M
    Infect Immun; 2015 May; 83(5):2168-74. PubMed ID: 25776748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.